BIOCRYST PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Durham, NC
SEC filing record 1 source field available
Fiscal year end
31 December
BIOCRYST PHARMACEUTICALS INC has filed 1,964 SEC EDGAR filings since 14 Feb 1995

SEC filing history

Showing 51-75 of 1,000 matching filings.

Per page
25
Current page
3
4

PRIMARY DOCUMENT

Filing date
03 Mar 2026
Reporting date
27 Feb 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-23186

144 filing

Filing date
02 Mar 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-44055

SCHEDULE 13G/A filing

Filing date
12 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-44055

SCHEDULE 13G filing

Filing date
09 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
23 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
27 Jan 2026
Reporting date
23 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-23186

FORM 8-K/A

Filing date
23 Jan 2026
Reporting date
14 Oct 2025
Next action
Verify source filing
3

3 filing

Filing date
09 Jan 2026
Reporting date
01 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
23 Dec 2025
Reporting date
19 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-23186

144 filing

Filing date
22 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2025
Reporting date
18 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2025
Reporting date
17 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Dec 2025
Reporting date
17 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Dec 2025
Reporting date
17 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-291678

EFFECT filing

Filing date
18 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-291678

424B3

Filing date
18 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Dec 2025
Reporting date
12 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .